» Articles » PMID: 35162766

Ambient UVR and Environmental Arsenic Exposure in Relation to Cutaneous Melanoma in Iowa

Overview
Publisher MDPI
Date 2022 Feb 15
PMID 35162766
Authors
Affiliations
Soon will be listed here.
Abstract

Intermittent sun exposure is the major environmental risk factor for cutaneous melanoma (CM). Cumulative sun exposure and other environmental agents, such as environmental arsenic exposure, have not shown consistent associations. Ambient ultraviolet radiation (UVR) was used to measure individual total sun exposure as this is thought to be less prone to misclassification and recall bias. Data were analyzed from 1096 CM cases and 1033 controls in the Iowa Study of Skin Cancer and Its Causes, a population-based, case-control study. Self-reported residential histories were linked to satellite-derived ambient UVR, spatially derived environmental soil arsenic concentration, and drinking water arsenic concentrations. In men and women, ambient UVR during childhood and adolescence was not associated with CM but was positively associated during adulthood. Lifetime ambient UVR was positively associated with CM in men (OR for highest vs. lowest quartile: 6.09, 95% confidence interval (CI) 2.21-16.8), but this association was not as strong among women (OR for highest vs. lowest quartile: 2.15, 95% CI 0.84-5.54). No association was detected for environmental soil or drinking water arsenic concentrations and CM. Our findings suggest that lifetime and adulthood sun exposures may be important risk factors for CM.

Citing Articles

Occupational Risk Factors for Skin Cancer: A Comprehensive Review.

Lee Y, Gu H, Lee Y, Yang M, Kim H, Kwon O J Korean Med Sci. 2024; 39(42):e316.

PMID: 39497567 PMC: 11538571. DOI: 10.3346/jkms.2024.39.e316.


Update of the risk assessment of inorganic arsenic in food.

Schrenk D, Bignami M, Bodin L, Chipman J, Del Mazo J, Grasl-Kraupp B EFSA J. 2024; 22(1):e8488.

PMID: 38239496 PMC: 10794945. DOI: 10.2903/j.efsa.2024.8488.


miR-656-3p inhibits melanomas in vitro and in vivo by inducing senescence via inhibiting LMNB2.

Sun J, Lui K, Pang Q, Xu M, Zhao H, Shao J J Cancer Res Clin Oncol. 2023; 149(12):10781-10796.

PMID: 37314513 DOI: 10.1007/s00432-023-04953-2.


Arsenic and cancer: Evidence and mechanisms.

Speer R, Zhou X, Volk L, Liu K, Hudson L Adv Pharmacol. 2023; 96:151-202.

PMID: 36858772 PMC: 10860672. DOI: 10.1016/bs.apha.2022.08.001.

References
1.
Elwood J, Jopson J . Melanoma and sun exposure: an overview of published studies. Int J Cancer. 1997; 73(2):198-203. DOI: 10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r. View

2.
Weir H, Marrett L, Cokkinides V, Barnholtz-Sloan J, Patel P, Tai E . Melanoma in adolescents and young adults (ages 15-39 years): United States, 1999-2006. J Am Acad Dermatol. 2011; 65(5 Suppl 1):S38-49. PMC: 3254089. DOI: 10.1016/j.jaad.2011.04.038. View

3.
Cust A, Jenkins M, Goumas C, Armstrong B, Schmid H, Aitken J . Early-life sun exposure and risk of melanoma before age 40 years. Cancer Causes Control. 2011; 22(6):885-97. DOI: 10.1007/s10552-011-9762-3. View

4.
Berwick M, Buller D, Cust A, Gallagher R, Lee T, Meyskens F . Melanoma Epidemiology and Prevention. Cancer Treat Res. 2015; 167:17-49. DOI: 10.1007/978-3-319-22539-5_2. View

5.
Chiarugi A, Quaglino P, Crocetti E, Nardini P, De Giorgi V, Borgognoni L . Melanoma density and relationship with the distribution of melanocytic naevi in an Italian population: a GIPMe study--the Italian multidisciplinary group on melanoma. Melanoma Res. 2014; 25(1):80-7. DOI: 10.1097/CMR.0000000000000113. View